EUREKA

Doing business
through technology

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.

EUREKA PROJECT > 3371 GENE TRANSFER AGENTS

DEVELOPMENT AND COMMERCIALISATION OF POLYFUNCTIONAL PYRIDINIUM DERIVATIVES AS POTENTIAL GENE DELIVERY AGENTS

IN ORDER TO FIND NEW EFFICIENT AND SAFE AGENTS FOR GENE DELIVERY, THE GOAL IS TO DEVELOP AND PRODUCE ALREADY SYNTHESIZED AND DESIGNED NOVEL CHARGED AMPHIPHILES ON THE BASIS OF PYRIDINIUM DERIVATES.

Status > FINISHED - 28-Sep-2009

Technological Area
6.1.7 / Gene - DNA Therapy

Market Area

Start Date > 01-Jan-2005
End date > 01-Jun-2009

Duration > 53 Months
Actual cost > 0.07 M€

Participating countries > LATVIA, FINLAND

Main contact

BAPEKS, Ltd.
AZENES IELA, 14
1048 -RIGA > LATVIA
Tel. +371 67 61 59 78
Fax. +371 67 61 59 78

DR. SC. UDO KALEJS > DIRECTOR
bapeks@apollo.lv

http://www.bapeks.com

Organisation type > SME